TNFRSF10A and breast cancer: Recently, mutations of TRAIL-R1 and -R2 were reported in breast cancers and these mutations were found more frequently in the metastatic tumours, suggesting that mutations in TRAIL-R1 and -R2 are possible mechanisms to escape TRAIL-induced apoptosis of tumour cells (Shin et al, 2001).